These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 6978147

  • 1. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF, Fox RM.
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [Abstract] [Full Text] [Related]

  • 2. The biochemical and clinical consequences of 2'-deoxycoformycin in T cell chronic lymphocytic leukaemia.
    Hallam LJ, Van der Weyden MB, Ackland SP, Bagnara AS, Whiteside MG.
    Scand J Haematol; 1984 Jan; 32(1):55-64. PubMed ID: 6607510
    [Abstract] [Full Text] [Related]

  • 3. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A, Pugh L, Israels LG, Johnston JB.
    Cancer Res; 1988 Jul 15; 48(14):3981-6. PubMed ID: 3260129
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N, Russell N, Ganeshaguru K, Jackson BF, Piga A, Prentice HG, Foa R, Hoffbrand AV.
    Br J Haematol; 1984 Jan 15; 56(1):107-19. PubMed ID: 6231047
    [Abstract] [Full Text] [Related]

  • 5. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
    Begleiter A, Glazer RI, Israels LG, Pugh L, Johnston JB.
    Cancer Res; 1987 May 01; 47(9):2498-503. PubMed ID: 3494509
    [Abstract] [Full Text] [Related]

  • 6. Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycin.
    Russell NH, Prentice HG, Lee N, Piga A, Ganeshaguru K, Smyth JF, Hoffbrand AV.
    Br J Haematol; 1981 Sep 01; 49(1):1-9. PubMed ID: 6974003
    [Abstract] [Full Text] [Related]

  • 7. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ, Kimball AP.
    Cancer Res; 1984 Feb 01; 44(2):461-6. PubMed ID: 6362851
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul 01; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
    Matsumoto SS, Yu AL, Yu J.
    Cancer Invest; 1985 Jul 01; 3(3):225-33. PubMed ID: 3873981
    [Abstract] [Full Text] [Related]

  • 13. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia.
    Venner PM, Glazer RI, Blatt J, Sallan S, Rivera G, Holcenberg JS, Lipton J, Murphy SB, Poplack DG.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4508-11. PubMed ID: 6975654
    [Abstract] [Full Text] [Related]

  • 14. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM, Henderson JF.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1545-51. PubMed ID: 6980005
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS, Hershfield MS.
    Proc Natl Acad Sci U S A; 1982 Apr 15; 79(8):2673-7. PubMed ID: 6283540
    [Abstract] [Full Text] [Related]

  • 16. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB, Begleiter A, Pugh L, Leith MK, Wilkins JA, Cavers DJ, Israels LG.
    Cancer Res; 1986 Apr 15; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [Abstract] [Full Text] [Related]

  • 17. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS, Koller CA, Kelley WN.
    Adv Exp Med Biol; 1979 Apr 15; 122B():347-50. PubMed ID: 317568
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition.
    Koller CA, Mitchell BS, Grever MR, Mejias E, Malspeis L, Metz EN.
    Cancer Treat Rep; 1979 Apr 15; 63(11-12):1949-52. PubMed ID: 316725
    [No Abstract] [Full Text] [Related]

  • 19. DNA repair in nondividing human lymphocytes: inhibition by deoxyadenosine.
    Cohen A, Thompson E.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1585-8. PubMed ID: 3485013
    [Abstract] [Full Text] [Related]

  • 20. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD, Ganeshaguru K, Knauf W, Dietz G, Trede I, Hoffbrand AV, Hunstein W.
    Leuk Res; 1989 Apr 15; 13(4):269-78. PubMed ID: 2785618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.